Proteolysis targeting chimeras (PROTACs) in cancer therapy

Ocana, A; Pandiella, A

Ocana, A (corresponding author), Hosp Clin San Carlos, Med Oncol Dept, Expt Therapeut Unit, Madrid, Spain.; Ocana, A (corresponding author), IdISSC, Madrid, Spain.; Ocana, A (corresponding author), Ctr Invest Biomed Red Oncol CIBERONC, Madrid, Spain.; Ocana, A (corresponding author), Castilla La Mancha Univ UCLM, Ctr Reg Invest Biomed, Albacete, Spain.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2020; 39 (1):

Abstract

Exploitation of the protein degradation machinery as a therapeutic strategy to degrade oncogenic proteins is experiencing revolutionary advances with ......

Full Text Link